4 European Projects Found
Searched on 125080 European Projects
FINISHED
European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults (ENS@T-CANCER)
Start date: Jan 1, 2011, End date: Jun 30, 2016,
Among patients with adrenal masses Adrenocortical carcinoma (ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis. Due to this poor clinical outcome, concomitant hormone dysregulation and limited treatment options the two cancer entities severely impact on affected patients. However, the rarity of the tumors also impedes clinical studies which ar ...
Read Project
17
Partners Participants
FINISHED
The European Network for Translational Research in Atrial Fibrillation (EUTRAF)
Start date: Nov 1, 2010, End date: Oct 31, 2015,
"The initiation and perpetuation of atrial fibrillation (AF) can be regarded as a complication of a progressive transformation of the structure and functional properties of the atria. This transformation is the result of complex and multiple changes at the molecular, cellular and organ levels which interact to form the basis for proarrhythmic mechanisms in AF. Numerous individual and environmental ...
Read Project
20
Partners Participants
FINISHED
ScalPL : A Scalable Programming Language (ScalPL)
Start date: Oct 1, 2008, End date: Sep 30, 2014,
"The goal of this project is the development of a growable programming language: a language whose vocabulary can easily be extended for purposes such as the development of domain-specific languages. The proposal addresses the long-standing ""holy grail"" of programming: Removing the ""representational gap"", making a program look like a description of a domain expert. This project is certainly not ...
Read Project
2
Partners Participants
FINISHED
Targeting the tumour microenvironment to improve pancreatic cancer prognosis (EPC-TM-Net)
Start date: Feb 1, 2011, End date: Jul 31, 2014,
Pancreatic cancer is one of the most lethal human cancers with a five-year survival rate of less than 5%. Late presentation and a high level of resistance to chemotherapeutic drugs are among the major reasons for this dismal prognosis. The presence of the highest degree of desmoplasia among all solid tumours and the fact that chronic inflammatory pancreatic disease is associated with an increased ...
Read Project
